Kim Allan Williams

Dr. Kim Allan Williams

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2017 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
HPHena Patel
Hena Patel
SCSonal Chandra
Sonal Chandra
SASarah Alexander
Sarah Alexander
JSJeffrey Soble
Jeffrey Soble
KWKim Allan Williams
Kim Allan Williams

1 July 2017 in JACC
Verified
Journal Article
Closed access
KWKim Allan Williams
Kim Allan Williams
HPHena Patel
Hena Patel

11 September 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
KWKim Allan Williams
Kim Allan Williams
AJArshad A. Javed
Arshad A. Javed
MHMuhammad S. Hamid
Muhammad S. Hamid
AWAmy M. Williams
Amy M. Williams
In 2013, more than 2200 U.S. hospitals forfeited a total of approximately $280 million in Medicare funds because their readmission rates for congestive heart failure, pneumonia, and acute myocardial infarction exceeded expected rates; these readmission penalties were stipulated by the Affordable Care Act.1 We evaluated 2013 and 2014 readmission penalties levied against hospitals in Detroit, as compared with penalties assessed against hospitals in other large cities in the East North Central region of the United States (as defined by the U.S. Census), and we correlated this information with census-derived socioeconomic data.2 We also compared readmission penalties for hospitals in the large cities with penalties for hospitals in the remainder of the respective state.

1 March 2022 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
MIMashaal Ikram
Mashaal Ikram
KWKim Allan Williams
Kim Allan Williams

21 April 2016 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
RDRami Doukky
Rami Doukky
NFNathan Frogge
Nathan Frogge
AAAndrew Appis
Andrew Appis
KHKathleen Hayes
Kathleen Hayes
GKGeorge Khoudary
George Khoudary
KWKim Allan Williams
Kim Allan Williams
The impact of appropriate use criteria (AUC) for myocardial perfusion imaging (MPI) with SPECT on the estimated lifetime attributable risk (LAR) of cancer is unknown. Methods: A cohort of 1,511 consecutive patients who underwent clinically indicated 99mTc-setamibi MPI were categorized into appropriate/uncertain (n = 823) versus inappropriate (n = 688) use groups according to the 2009 AUC and were prospectively followed for 27 ± 10 mo. Logistic regression models were used to determine the annualized probability of major adverse cardiac events (MACE) of cardiac death or myocardial infarction and the probability of revascularization within 6 mo of MPI, accounting for relevant covariates. We determined LAR for each subject on the basis of accepted risk estimates. We calculated MPI’s benefit-to-risk ratios, defined by the annualized predicted MACE-to-LAR ratio and the predicted 6-mo-revascularization–to–LAR ratio. Results: During follow-up, there were 22 MACE and 29 6-mo revascularizations. The administered radioactivity and effective radiation doses absorbed were similar between the study groups. Patients with inappropriate MPI had significantly higher LAR (median, 0.08% vs. 0.06%, P < 0.001), lower predicted MACE-to-LAR ratio (median, 1.5 vs. 4.3, P < 0.001), and lower predicted 6-mo-revascularization–to–LAR ratio (median, 5.4 vs. 15.5, P < 0.001). Women had higher LAR (median, 0.08% vs. 0.07%, P < 0.001) and lower predicted MACE-to-LAR ratio (median, 1.9 vs. 3.3, P < 0.001) and 6-mo-revascularization–to–LAR ratio (median, 4.4 vs. 17.5, P < 0.001). However, appropriate/uncertain use negated the difference between men and women in LAR (P = 0.94) and the predicted MACE-to-LAR ratio (P = 0.97). Conclusion: Inappropriate MPI use is associated with excess cancer risk and lower MPI’s benefit-to-risk ratio. Appropriate/uncertain use neutralizes the sex gap in LAR with MPI.

8 May 2015 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
RDRami Doukky
Rami Doukky
KHKathleen Hayes
Kathleen Hayes
NFNathan Frogge
Nathan Frogge
NNNoreen Nazir
Noreen Nazir
FCFareed M. Collado
Fareed M. Collado
KWKim Allan Williams
Kim Allan Williams
Background: The impact of health insurance carrier and socioeconomic status (SES) on the adherence to appropriate use criteria (AUC) for radionuclide myocardial perfusion imaging (MPI) is unknown.Hypothesis: Health insurance carrier's prior authorization and patient's SES impact adherence to AUC for MPI in a fee‐for‐service setting.Methods: We conducted a prospective cohort study of 1511 consecutive patients who underwent outpatient MPI in a multi‐site, office‐based, fee‐for‐service setting. The patients were stratified according to the 2009 AUC into appropriate/uncertain appropriateness and inappropriate use groups. Insurance status was categorized as Medicare (does not require prior authorization) vs commercial (requires prior authorization). Socioeconomic status was determined by the median household income in the ZIP code of residence.Results: The proportion of patients with Medicare was 33% vs 67% with commercial insurance. The rate of inappropriate use was higher among patients with commercial insurance vs Medicare (55% vs 24%; P < 0.001); this difference was not significant after adjusting for confounders known to impact AUC determination (odds ratio: 1.06, 95% confidence interval: 0.62‐1.82, P = 0.82). The mean annual household income in the residential areas of patients with inappropriate use as compared to those with appropriate/uncertain use was $72 000 ± 21 000 vs $68 000 ± 20 000, respectively (P < 0.001). After adjusting for covariates known to impact AUC determination, SES (top vs bottom quartile income area) was not independently predictive of inappropriate MPI use (odds ratio: 0.9, 95% confidence interval: 0.53‐1.52, P = 0.69).Conclusions: Insurance carriers prior authorization and SES do not seem to play a significant role in determining physicians adherence to AUC for MPI.